Loading clinical trials...
Loading clinical trials...
An Open-label Safety Study of S-888711 in Adult Subjects With Relapsed Persistent or Chronic Immune Thrombocytopenia With or Without Prior Splenectomy
Conditions
Interventions
Lusutrombopag
Locations
19
United States
Investigator
Anaheim, California, United States
Investigator
Los Angeles, California, United States
Investigator
Washington D.C., District of Columbia, United States
Investigator
Boynton Beach, Florida, United States
Investigator
Jacksonville, Florida, United States
Investigator
Atlanta, Georgia, United States
Start Date
April 29, 2010
Primary Completion Date
June 30, 2011
Completion Date
June 30, 2011
Last Updated
February 26, 2021
NCT07104565
NCT07362238
NCT07362199
NCT07294365
NCT07175493
NCT06519565
Lead Sponsor
Shionogi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions